Top Stories

The diversity gap: How emerging technology can address long-standing inequality in clinical trials and save women’s lives 

Gaurica Chacko, VP and Global Life Sciences Head at Wipro, delves into how technology can rectify long-standing gender disparities in clinical trials, saving lives and advancing healthcare inclusivity.  Imagine this scenario: a woman visits the doctor....

Apple Hearing Study shares preliminary insights on tinnitus based on app-based assessments

Conducted in collaboration with the University of Michigan, the Apple Hearing Study advances the understanding of sound exposure and its impact on hearing health. Researchers have already collected about 400 million hours of calculated environmental sound...

Future Health Index 2024 global report: Healthcare leaders turn to AI to address critical gaps in patient care 

Royal Philips, a global leader in health technology, have announced the results of its Future Health Index 2024 report: Better care for more people. Launched at HLTH Europe, the ninth annual FHI global report shows that healthcare leaders are turning to...

Andy Coravos, Founder of HumanFirst 

Andy Coravos, founder of HumanFirst, recently acquired by ICON, discusses her journey in the industry, sharing insights on leveraging digital health technologies and wearables to manage chronic conditions. Drawing from her recent Lancet Digital Health...

From public health to tech giants: Shaping healthcare with Google 

We sat down with Dr Karen DeSalvo, Chief Health Officer at Google, who reflects on her exceptional journey, with a career deeply rooted in public health and social determinants, and joining Google amidst the rapid changes brought by the COVID-19 pandemic....

AbbVie and FutureGen announce license agreement to develop next-generation therapy for inflammatory bowel disease 

AbbVie and FutureGen Biopharmaceutical have announced a license agreement to develop FG-M701, a next generation TL1A antibody for the treatment of IBD currently in preclinical development, whilst utilising FutureGen’s Structure-based Targeted...

Galaxy AI is coming to new Galaxy watch for more motivational health 

Earlier this year, Samsung established the era of mobile AI with the launch of the Galaxy S24 series, and committed to introducing Galaxy AI on a wider range of devices. True to this promise, Samsung is now bringing Galaxy AI to Galaxy Watch, enhancing its...

Fast-growing mental health solution partners with Headspace 

Uwill, the nation’s fastest-growing mental health and wellness solution that serves more than 2 million students at 300 colleges in 50 states and 40 countries, has announced an exclusive partnership to offer Headspace, the world’s most...

Microsoft announces expansion of trustworthy AI Network to Europe

At the HLTH Europe conference, the Trustworthy and Responsible AI Network (TRAIN), a consortium of healthcare leaders, announced its expansion to Europe with the objective to help organisations in the region operationalize responsible AI through...

Bank Midwest’s OnePlace.bank goes live with Finastra to deliver tailored financial services to the healthcare sector 

Finastra has announced that Bank Midwest, an employee-owned bank with locations throughout Iowa, Minnesota and South Dakota, has launched OnePlace.bank, a digital bank powered by Finastra, focused exclusively on the financial needs of the healthcare...

Tempus expands collaboration with AstraZeneca to support guideline-directed biomarker testing in NSCLC 

Tempus, a leader in Artificial Intelligence and precision medicine, has announced an expansion of its collaboration with AstraZeneca, which leverages Tempus Next to arm physicians with technology that supports the delivery of guideline-directed biomarker...

The intersection of telemedicine decline and rising NEMT demand has implications for outpatient care and healthcare systems 

Telemedicine’s 15 minutes of fame appear to be fizzling, a trend that could compound the already staggering financial losses — a whopping US$150 billion annually — for the healthcare industry due to patient no-shows. One of the most common...